Treating inflammation by blocking interleukin-1 in humans
Top Cited Papers
- 23 November 2013
- journal article
- review article
- Published by Elsevier BV in Seminars in Immunology
- Vol. 25 (6), 469-484
- https://doi.org/10.1016/j.smim.2013.10.008
Abstract
No abstract availableKeywords
This publication has 170 references indexed in Scilit:
- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]The American Journal of Cardiology, 2013
- Current Status of Understanding the Pathogenesis and Management of Patients With NOMID/CINCACurrent Rheumatology Reports, 2011
- The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin SensitivityCell Metabolism, 2010
- Engagement of fatty acids with toll‐like receptor 2 drives interleukin‐1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal–induced gouty arthritisArthritis & Rheumatism, 2010
- How interleukin‐1β induces gouty arthritisArthritis & Rheumatism, 2010
- Inflammatory arthritis in caspase 1 gene–deficient mice: Contribution of proteinase 3 to caspase 1–independent production of bioactive interleukin‐1βArthritis & Rheumatism, 2009
- Inflammation in Atherosclerosis From Pathophysiology to PracticeJournal of the American College of Cardiology, 2009
- A pilot study to evaluate the safety and efficacy of the long‐acting interleukin‐1 inhibitor rilonacept (interleukin‐1 trap) in patients with familial cold autoinflammatory syndromeArthritis & Rheumatism, 2008
- The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean feverEuropean Journal of Pediatrics, 2007
- The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1β productionProceedings of the National Academy of Sciences of the United States of America, 2006